HIGHLIGHTS
- who: A. Sanz from the Complutense University imas12, Hospital , de Octubre, Madrid, Spain TriNetX, LLC, Cambridge, MA, USA. have published the Article: Outcomes and patterns of treatment in chronic myeloid leukemia, a global perspective based on a real-world data global network, in the Journal: (JOURNAL) of 29/03/2022
SUMMARY
Lastly, with regards to infectious diseases (all kinds), no difference was observed comparing the incidence between CML and non-oncologic patients. Taken together, these data reinforce the importance of TKI discontinuation whenever possible to avoid further adverse events. To assess the landscape . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.